HUM
Humana Inc.
Price performance
Sep 18, 2026About
Company activity
41 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 09/01 | HUM | 8-K | Humana Inc. Reaffirms FY 2026 Earnings Guidance | — | — | — |
| 07/29 | HUM | 8-K | Humana Appoints Two New Independent Directors | — | — | — |
| 07/29 | HUM | 8-K | Humana Inc. Revises Full Year 2026 GAAP EPS Guidance | — | — | — |
| 06/01 | HUM | 8-K | Humana Inc. Reaffirms FY 2026 Earnings Guidance | — | — | — |
| 05/19 | HUM | 8-K | Humana Inc. Completes Issuance of $1.5 Billion in Pre-Capitalized Trust Securities | — | — | — |
| 04/29 | HUM | 8-K | Humana Reports Strong 1Q26 Financial Results and Revises FY 2026 Guidance | — | — | — |
| 04/20 | HUM | 8-K | Humana Inc. Announces Election of Directors and Approval of Proposals at Annual Meeting | — | — | — |
| 04/10 | HUM | 8-K | Humana Appoints Robert S. Field to Board of Directors | — | — | — |
| 03/09 | HUM | 8-K | Humana Inc. Issues $1.0 Billion in Subordinated Notes | — | — | — |
| 03/02 | HUM | 8-K | Humana Inc. Reaffirms FY 2026 Earnings Guidance | — | — | — |
| 02/11 | HUM | 8-K | Humana Reports 2025 Financial Results and Provides 2026 Guidance | — | — | — |
| 12/16/25 | HUM | 8-K | Humana Announces Retirement of Insurance Segment President and Leadership Transition | — | — | — |
| 12/01/25 | HUM | 8-K | Humana Inc. Reaffirms FY 2025 Guidance in Investor Meetings | — | — | — |
| 11/05/25 | HUM | 8-K | Humana Inc. Reports Q3 2025 Financial Results and Revises Annual Guidance | — | — | — |
| 10/02/25 | HUM | 8-K | Humana Inc. Discloses 2026 Medicare Advantage Star Ratings and 2025 Earnings Guidance | — | — | — |
| 08/29/25 | HUM | 8-K | Humana Inc. to Reaffirm FY 2025 Guidance in Upcoming Investor Meetings | — | — | — |
| 07/30/25 | HUM | 8-K | Humana Inc. Reports Second Quarter 2025 Financial Results and Raises Guidance | — | — | — |
| 06/02/25 | HUM | 8-K | Humana Inc. Reaffirms 2025 Guidance and Announces Investor Meetings | — | — | — |
| 05/30/25 | HUM | 8-K | Humana Inc. Enters $5.0 Billion Revolving Credit Agreement | — | — | — |
| 04/30/25 | HUM | 8-K | Humana Inc. Reports First Quarter 2025 Financial Results and Revises Earnings Guidance | — | — | — |
| 04/18/25 | HUM | 8-K | Humana Inc. Reports Voting Results from Annual Meeting | — | — | — |
| 03/31/25 | HUM | 8-K | Humana Inc. Announces Additional $250 Million Senior Notes Offering | — | — | — |
| 03/05/25 | HUM | 8-K | Humana Inc. Announces $1.25 Billion Debt Offering | — | — | — |
| 03/03/25 | HUM | 8-K | Humana Inc. Reaffirms FY 2025 Earnings Guidance | — | — | — |
| 02/11/25 | HUM | 8-K | Humana Reports Q4 2024 Results and Provides 2025 Guidance | — | — | — |
| 12/03/24 | HUM | 8-K | Humana Announces CFO Transition | — | — | — |
| 10/30/24 | HUM | 8-K | Humana Inc. Reports Third Quarter 2024 Financial Results and Updates Guidance | — | — | — |
| 10/23/24 | HUM | 8-K | Humana Appoints Gordon Smith to Board of Directors | — | — | — |
| 10/02/24 | HUM | 8-K | Humana's 2025 MA Star Ratings Decline Impacting Future Quality Payments | — | — | — |
| 09/03/24 | HUM | 8-K | Humana Reaffirms Financial Guidance for FY 2024 | — | — | — |
| 07/31/24 | HUM | 8-K | Humana Reports Second Quarter 2024 Financial Results and Revises Full-Year Guidance | — | — | — |
| 06/05/24 | HUM | 8-K | Humana Inc. Announces New Revolving Credit Agreements | — | — | — |
| 06/03/24 | HUM | 8-K | Humana Inc. Reaffirms FY 2024 Earnings Guidance | — | — | — |
| 05/13/24 | HUM | 8-K | Humana Announces CEO Transition Effective July 1, 2024 | — | — | — |
| 04/24/24 | HUM | 8-K | Humana Inc. Reports Q1 2024 Financial Results and Revises FY 2024 Guidance | — | — | — |
| 04/19/24 | HUM | 8-K | Humana Inc. Announces Election Results for Directors and Advisory Votes | — | — | — |
| 03/13/24 | HUM | 8-K | Humana Inc. Announces $2.25 Billion Debt Offering | — | — | — |
| 03/05/24 | HUM | 8-K | Humana Inc. Management Team to Meet with Investors to Reaffirm FY 2024 Guidance | — | — | — |
| 02/05/24 | HUM | 8-K | Humana Inc. Responds to CMS's Preliminary 2025 Medicare Advantage Payment Rates | — | — | — |
| 01/25/24 | HUM | 8-K | Humana Reports Fourth Quarter 2023 Financial Results and Initial 2024 Guidance | — | — | — |
| 01/18/24 | HUM | 8-K | Humana Inc. Updates Medicare Advantage Enrollment Projection and 2023 EPS | — | — | — |
HUM filing record
Humana Inc. (HUM): 41 8-K filings summarized, the most recent on Sep 1, 2026.
What the 8-K filings said
- Sep 1, 2026 · low impact
Humana Inc. has reaffirmed its guidance for at least $6.52 in diluted earnings per share (EPS) and at least $9.00 in adjusted earnings per share (Adjusted EPS) for the year ending December 31, 2026. This guidance is consistent with the information provided in the Company's press release dated July 29, 2026. The…
Humana Inc. Reaffirms FY 2026 Earnings Guidance - Jul 29, 2026 · medium impact
Humana Inc. announced on July 28, 2026, the election of Paul Smith and Frederick Crawford to its Board of Directors, effective immediately. Smith, with over 30 years of experience in scaling go-to-market strategies at leading enterprise technology companies, currently serves as Chief Commercial Officer at Anthropic…
Humana Appoints Two New Independent Directors - Jul 29, 2026 · high impact
Humana Inc. reported second quarter 2026 earnings per share (EPS) of $5.73 on a GAAP basis and $7.61 on an Adjusted basis. The company affirmed its full year 2026 Adjusted EPS guidance of 'at least $9.00' but revised its GAAP EPS guidance to 'at least $6.52'. Humana also reported a 2Q26 Insurance segment GAAP benefit…
Humana Inc. Revises Full Year 2026 GAAP EPS Guidance - Jun 1, 2026 · high impact
Humana Inc. has reaffirmed its guidance for diluted earnings per share (EPS) of at least $8.36 and adjusted EPS of at least $9.00 for the year ending December 31, 2026. This guidance is consistent with the company's previous announcement on April 29, 2026. The company uses adjusted EPS, a non-GAAP measure, to provide…
Humana Inc. Reaffirms FY 2026 Earnings Guidance - May 19, 2026 · medium impact
On May 15, 2026, Humana Inc. completed the issuance and sale of $1.5 billion in Pre-Capitalized Trust Securities (P-Caps) through two trusts, the 2036 Trust and the 2055 Trust. The P-Caps provide Humana with on-demand capital and liquidity by allowing the issuance of up to $750 million in 6.062% Senior Notes due 2036…
Humana Inc. Completes Issuance of $1.5 Billion in Pre-Capitalized Trust Securities
SEC filings in the last five years
- 77 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K
- 1 Form 8-K/A